Trial Profile
Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 11 Jul 2018
Price :
$35
*
At a glance
- Drugs Mosapride/rebamipide (Primary) ; Mosapride
- Indications Dyspepsia
- Focus Registrational; Therapeutic Use
- Sponsors Ildong Pharmaceutical
- 12 Aug 2016 New trial record